1. Home
  2. BLMN vs TRVI Comparison

BLMN vs TRVI Comparison

Compare BLMN & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • TRVI
  • Stock Information
  • Founded
  • BLMN 1988
  • TRVI 2011
  • Country
  • BLMN United States
  • TRVI United States
  • Employees
  • BLMN N/A
  • TRVI N/A
  • Industry
  • BLMN Restaurants
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • TRVI Health Care
  • Exchange
  • BLMN Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • BLMN 736.6M
  • TRVI 725.7M
  • IPO Year
  • BLMN 2012
  • TRVI 2019
  • Fundamental
  • Price
  • BLMN $9.38
  • TRVI $6.85
  • Analyst Decision
  • BLMN Hold
  • TRVI Strong Buy
  • Analyst Count
  • BLMN 11
  • TRVI 9
  • Target Price
  • BLMN $12.25
  • TRVI $19.94
  • AVG Volume (30 Days)
  • BLMN 2.4M
  • TRVI 1.7M
  • Earning Date
  • BLMN 08-06-2025
  • TRVI 08-07-2025
  • Dividend Yield
  • BLMN 6.39%
  • TRVI N/A
  • EPS Growth
  • BLMN N/A
  • TRVI N/A
  • EPS
  • BLMN N/A
  • TRVI N/A
  • Revenue
  • BLMN $3,930,996,000.00
  • TRVI N/A
  • Revenue This Year
  • BLMN $1.33
  • TRVI N/A
  • Revenue Next Year
  • BLMN $1.55
  • TRVI N/A
  • P/E Ratio
  • BLMN N/A
  • TRVI N/A
  • Revenue Growth
  • BLMN N/A
  • TRVI N/A
  • 52 Week Low
  • BLMN $6.09
  • TRVI $2.36
  • 52 Week High
  • BLMN $21.45
  • TRVI $7.48
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 51.70
  • TRVI 64.33
  • Support Level
  • BLMN $9.06
  • TRVI $6.61
  • Resistance Level
  • BLMN $9.65
  • TRVI $7.05
  • Average True Range (ATR)
  • BLMN 0.54
  • TRVI 0.34
  • MACD
  • BLMN -0.09
  • TRVI 0.12
  • Stochastic Oscillator
  • BLMN 47.75
  • TRVI 95.12

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: